Table 5.
Type of graft | Lead author | Year | Satisfaction, % (n/N) | Reoperation, % (n/N) | Complications, % (n/N) |
|||||
---|---|---|---|---|---|---|---|---|---|---|
Altered sensation | Recovery from altered sensation | Hematoma | Pain | Edema | Infection | |||||
Xenograft | Sayedahmed19 | 2017 | 86.0 (37/43) | 4.7 (2/43) | 9.3 (4/43) | NM | NM | 7.0 (3/43) | NM | 0.0 (0/43) |
Cosentino20 | 2016 | NM | NM | NM | NM | NM | 6.8 (3/44) | 11.4 (5/44) | 2.3 (1/44) | |
Knoll21 | 2007 | NM | 4.3 (7/162) | 16.7 (27/162) | 100.0 (27/27) | 1.9 (3/162) | 0.0 (0/162) | NM | 0.0 (0/162) | |
Sansalone22 | 2011 | 97† | NM | 3.2 (5/157) | NM | NM | NM | NM | NM | |
Allograft | Sampaio23 | 2002 | NM | NM | 22.5 (9/40) | 88.9 (8/9) | 0.0 (0/40) | NM | 20.0 (8/40) | NM |
Autograft | Kadioglu24 | 2018 | NM∗ | 0.7 (1/144) | NM | NM | NM | NM | NM | NM |
Kalsi25 | 2005 | NM§ | 0.9 (1/113) | 8.8 (10/113) | 80.0 (8/10) | 0.9 (1/113) | 2.7 (3/113) | NM | NM | |
Montorsi26 | 2000 | 88.0 (44/50) | NM | 2.0 (1/50) | NM | 4.0 (2/50) | NM | NM | 2.0 (1/50) | |
Akkus27 | 2001 | NM | NM | NM‖ | 100‖ | NM | NM | NM‖ | NM | |
El Sakka13 | 1998 | 92.0 (103/112) | NM | 9.8 (11/112) | NM | NM | NM | 2.7 (3/112) | 2.7 (3/112) | |
Multiple | Flores15 | 2011 | NM | NM | 16.1 (9/56) | 100.0 (9/9) | NM | NM | NM | NM |
Chung28 | 2011 | <35‡ | NM | 13.0 (6/46) | NM | NM | NM | NM | NM | |
Range | – | – | 88.0–92.0 | 0.7–4.7 | 2.0–22.5 | 80.0–100.0 | 0.0–4.0 | 0.0–7.0 | 0.0–20.0 | 0.0–2.7 |
Sansalone et al and Chung et al excluded from range.
Success 75.0% (108/144).
Of partners.
>65% dissatisfied.
Success 92.9% (105/113).
No total value given.